> **Historical notice (Decision G).**
> This is a **point-in-time record** of repository state as observed on 25 July 2026, preserved unaltered. Its findings are not rewritten here.
> Several factual claims below are **no longer current** — including descriptions of `Glossary.md`, `Roadmap.md`, and `Product Vision.md` / `Product Philosophy.md` / `Assumptions.md` as empty or minimal. Those documents were subsequently populated or restructured under Decisions A2, D and L.
> For current repository state, consult the documents this notice names directly, or `PROJECT_CONTEXT.md`.

---

I'll start by exploring the repository structure.

Repository is small and document-only. Let me read everything.

I've read every file in the repository. Nothing was modified.

---

# 1. Repository Summary

## Structure

Nine numbered domain folders plus three root files. Only two folders contain substantive content.

| Location | State |
|---|---|
| Root | [README.md](README.md) (2.9 KB), [CLAUDE.md](CLAUDE.md) (2.4 KB), `PROJECT_CONTEXT.md` **(empty)**, `.gitignore` **(empty)** |
| `01_Strategy` | Phase 1 (54 KB), Phase 2 (89 KB), [Architecture Principles.md](01_Strategy/Architecture%20Principles.md), [Decision Log.md](01_Strategy/Decision%20Log.md), [Glossary.md](01_Strategy/Glossary.md) (word list only), [Roadmap.md](01_Strategy/Roadmap.md) (14 lines), README. `Product Vision.md`, `Product Philosophy.md`, `Assumptions.md` **all empty** |
| `02_Product` | Phase 3 PRD (133 KB), Phase 4 IA (74 KB), Phase 5 User Flows (60 KB), [Assessment-Lifecycle.md](02_Product/Assessment-Lifecycle.md) ADR (18 KB). README **empty** |
| `03_Design`, `04_Development` | README stubs only |
| `05_Research`, `06_Legal`, `07_Marketing`, `08_Meetings`, `99_Archive` | **Empty READMEs** |

~430 KB of documentation, ~99% of it in six documents. This is a **documentation-only repository** — no code, no design assets, no schema. It is also **not under version control** (no `.git`), despite a workflow whose central mechanism is freezing.

## Document lineage

The five phase documents form a strict derivation chain, each declaring its baseline and its handoff:

```
Phase 1 (landscape, analysis only)
   └─► Phase 2 (positioning, business model, MVP scope, metrics)
          └─► Phase 3 (product architecture PRD — the master blueprint)
                 └─► Phase 4 (information architecture)
                        └─► Phase 5 (user flows)
                 ▲
    Assessment Lifecycle ADR ──┘  (resolves a Phase 2↔Phase 3 contradiction;
                                   supersedes conflicting text in Phases 2–4)
```

The chain is unusually disciplined. Each document states what it inherits, what it may not change, and what it hands forward. Phase 3 §26 names five things Phase 4 must not change; Phase 4 §26.1 names seven things Phase 5 must not change; Phase 5 §12 names what Phase 6 must not do. Phase 5 §9 explicitly *reports* three boundary problems rather than fixing them — which is the repository's stated rule being followed correctly.

## Governance model

[CLAUDE.md](CLAUDE.md) and [README.md](README.md) establish: frozen phases are immutable; ADRs record permanent decisions; the [Decision Log](01_Strategy/Decision%20Log.md) records accepted decisions (13 accepted, 1 open, D-2026-001 → D-2026-013); contradictions get reported, not silently fixed; no permanent architectural decision may be invented without approval.

---

# 2. Architecture Summary

## The five shaping decisions (Phase 3 §1.2)

| ID | Decision | Consequence accepted |
|---|---|---|
| **D1** | Rules-as-data with a generic temporal engine | Rule-authoring discipline most teams underestimate; adding a jurisdiction = data + adapter + tests, **zero application code** |
| **D2** | Three-zone separation (Confidential / Public Corpus / Outcome Metadata) | Some analytically valuable queries become impossible by design |
| **D3** | Modular monolith, extract later | Requires enforced boundaries without network calls forcing them |
| **D4** | Two-sided tenancy with matter-scoped grants | Permission model materially more complex than standard RBAC |
| **D5** | Async-first AI orchestration | Real job infrastructure required at MVP; UI must do progressive disclosure |

## The permanent principles ([Architecture Principles.md](01_Strategy/Architecture%20Principles.md), AP-01…AP-14)

Invention-first · rules-as-data · confidentiality-first (three zones) · provenance mandatory · humans make legal decisions · Layer 1 = Layer 2 · deadline safety · explainability before intelligence · modular growth · honest product · global by design · documentation is product · language builds trust · status is two-dimensional.

## Layer model

```
L5  External surface — API, webhooks, developer portal              (V3)
L4  Internal operations — Docket Health ★, Quality, Marketplace Ops,
    Rule Authoring ★, Trust & Incident, Business
L1  Client        │ L2  Professional      │ L3  Institutional        (V2)
    Public Register│     Agent Console     │     Disclosure Intake
    Invention Vault│     Drafting (V2)     │     Ownership/Approvals
    Assessment     │     Prosecution (V2)  │     Budget & Compliance
    Cost Planner   │     Agent Docket      │     Institutional Portfolio
    Agent Matching │     Profile & Outcomes│
    Matter, Portfolio, Renewals, Guidance  │
L0  Platform services — Identity/Tenancy/Access · DEADLINE & RULES ENGINE ★
    Search & Retrieval · PROVENANCE & EVIDENCE ★ · Document Mgmt ·
    AI Orchestration · Notification · Billing · Integration Hub ·
    Event Log (immutable) · Outcome Data
```

★ = the modules that must be correct above all others.

## Entity spine

**Invention is the root** (P5, D-2026-001). Everything else hangs off it:

`Party → Workspace / Agent Org / Institution → Invention → Disclosure (versioned, immutable once used) → Assessment → Assertion → Citation → Document`, and separately `Engagement → Matter → Application → {Event, Deadline, Document, Renewal}`, with `Event + Rule → Deadline` as derived state.

`Party_Invention_Role` is many-to-many with role qualifiers (inventor / applicant / owner / assignee) — this single modelling choice is what makes the university case (researcher = inventor, institution = owner) expressible without a separate surface.

## Enforcement mechanisms (not policy — structure)

- **Provenance**: `Assertion` has a `NOT NULL` relationship to ≥1 `Citation`; `Citation` requires `(document_id, span_start, span_end, retrieved_at, retrieval_method)`. Prompts are a supplement, never the mechanism. Requires **content-hash-based stable span addressing** — Phase 3 §17.3 flags that if this is wrong, P2 is unenforceable.
- **Zone separation**: the Zone 3 pipeline's database credentials have *no grant* on Zone 1 tables (BR-15). Not convention.
- **AI tiering**: T0 mechanical / T1 assistive / T2 legally significant (mandatory named-agent review) / T3 prohibited to AI entirely. Tier is a property of the *task definition*, and a T2 output cannot be released without a `ReviewDecision`.
- **Deadlines**: derived state only. Nobody types a due date. Every deadline carries a computation trace citing its statutory source. Four independent verification layers (golden test suite, official cross-check, human confirmation gate, anomaly detection).
- **Access**: `CAN(actor, action, resource) = role_grants ∧ scope_matches ∧ relationship_active ∧ confidentiality_tier_permits ∧ ¬conflict_flagged`.

## Twenty business rules (BR-01…BR-20)

The load-bearing ones: BR-01 (no assessment release without agent review), BR-02 (no assertion without resolvable citation), BR-03 (dual confirmation on critical deadlines), BR-09 (no AI output as sole basis for filing/abandonment/amendment), BR-11 (passive lapse prohibited — non-response escalates), BR-15 (Zone 3 has no Zone 1 read), BR-20 (disclosure version immutable on release/filing).

## The ADR's contribution

The [Assessment Lifecycle ADR](02_Product/Assessment-Lifecycle.md) resolves the one genuine contradiction found between phases: Phase 2's conversion metric required assessment *before* payment; Phase 3's access model required an Engagement *before* an agent could see anything. Resolution:

- Assessment is **free and precedes payment and Engagement**
- Reviewer assignment is **queue-based domain routing**, not the marketplace match
- A new, narrower **review grant** — one Disclosure version, one `ReviewDecision`, expires on release — permits pre-engagement access without weakening any confidentiality guarantee
- Reviewers are **compensated by the platform**; assessment review is a platform-borne COGS line
- "Hours, not seconds" is retired; a configurable committed review turnaround replaces it
- **"Marketplace" is reserved for the future licensing surface**; the MVP concept is "Agent Matching / Engagement"

---

# 3. Product Understanding

## What it is

An operating layer between an invention and the patent system — three integrated layers where every competitor owns one:

| Layer | Content | Business role |
|---|---|---|
| **The Record** | Disclosure capture, vault, docket, deadline engine, portfolio | Custody. The switching cost. Free-to-cheap. |
| **The Judgement** | AI assessment with human verification, cost modelling, abandon/renew | Differentiation. The trust engine. |
| **The Work** | Drafting, filing, prosecution, renewals by verified agents | Revenue and margin. |

## The strategic thesis

Patent services are a **lemons market** — the buyer cannot evaluate quality at purchase, or for 3–5 years afterwards. Predictable consequences: price becomes the only visible signal, sellers compete on trust theatre, good practitioners get undercut. Such markets are won not by being better but by **being first to make quality visible**. The instrument is outcome metadata — objection patterns, allowance rates, claim-scope retention, by agent, examiner and art unit — accumulated over years, unbuyable, unaccelerable with capital.

Simultaneously, AI has made expert analysis cheap, but every incumbent aimed it at organisations that *already have* IP departments. The front of the funnel — the person who doesn't yet know whether they have anything worth protecting — is unserved. That window is estimated at 24–36 months.

## Positioning

**"The most competent and most honest participant in a category built on opacity."** Explicitly *not* "the Apple of patent services" — Phase 2 §5.1 rejects that North Star on three grounds (Apple's premium is funded by hardware margin; Apple's design is about desire and nobody desires a patent; "premium" in a market where quality is unjudgeable is indistinguishable from overcharging). Models are **Stripe and Wise**.

## Audience sequencing

> Sell to startups. Build for agents. Court universities. Ignore enterprises until earned. Subsidise inventors because it's right and because it compounds.

The non-obvious call: **the registered patent agent (ICP-2, Priya) is arguably the most strategically important user**, because agent capacity is the hard, legally-enforced ceiling on the entire business. Layer 2 is co-equal with Layer 1, and parts of it should be built first — agents adopt tooling for their own 45 matters long before they take a marketplace matter.

## MVP

**Must exist:** free Indian search + status layer · structured disclosure capture · source-linked AI assessment · named human verification · lifetime cost model · agent matching with fixed prices · deadline & docket engine · client dashboard · document vault · minimum agent workspace.

**Must not exist:** autonomous drafting · analytics/landscaping · trademarks/designs/copyright · enterprise features · licensing marketplace · native apps · jurisdictions beyond IN+PCT · chemical/biosequence search · community forum · multilingual UI · any AI feature without source-linking.

**MVP proves exactly one thing:** that an inventor will trust an AI-assisted, human-verified assessment enough to pay for the filing that follows.

## The emotional core

Phase 1 observed that every testimonial across every Indian firm praised *communication*, not drafting quality — because communication is the only thing a client can actually perceive. The multi-year silence between filing and examination is the central unaddressed emotional job. The architectural answers are the **proactive-reassurance requirement** (send messages when *nothing* has happened) and the **silence view** — a designed screen, not an empty one, saying "Nothing has happened — and that's expected," with the last known fact, an honest expected range, an explicit "nothing is required from you," and two links that turn anxiety into understanding.

## The four numbers

Disclosure→filing conversion · agent-hours per matter · recurring revenue share · **missed deadlines (target zero; any non-zero value is a company-level incident)**.

## Product-design invariants inherited by Phase 6

Two-axis status (lifecycle × attention, always both, always independent) · three-depth progressive disclosure (state → reasoning → evidence, uniform across object types) · cross-tenancy invisibility (no stubs, no counts, no locked placeholders — a 404, because existence is itself confidential) · plain language leads and the term of art appears in the same view rather than replacing it · one price component in two configured modes · "Not pursued" is a first-class destination with a complete, dignified page.

---

# 4. Inconsistencies Observed

Reported, not corrected, per the repository rule. Ordered by consequence.

## A. Missing artifacts that other documents depend on

**A1 — The Stage Gate Review does not exist in the repository.** [Roadmap.md](01_Strategy/Roadmap.md) lists it as completed. The ADR's entire purpose is stated as resolving "Stage Gate Review findings C1 and G1." Phase 5 §9-B says the multi-inventor gap is "the gap the Stage Gate Review already flagged (§2.3)." A load-bearing document is referenced by section number and is absent. Findings C1 and G1 are recoverable from the ADR; the rest of the review is not.

**A2 — Four spine documents are empty:** `Product Vision.md`, `Product Philosophy.md`, `Assumptions.md`, `PROJECT_CONTEXT.md`. All four are listed as contents in [README.md](README.md) and [01_Strategy/README.md](01_Strategy/README.md). The *content* exists — Phase 2 §1 (Mission), §2 (Vision), §3 (seven principles), §0 (five assumptions) — but has never been extracted into the durable, implementation-independent form the repository structure implies. Anyone onboarding must read an 89 KB strategy document to find the mission.

## B. Three competing statements of the principles

CLAUDE.md, README.md and [Architecture Principles.md](01_Strategy/Architecture%20Principles.md) each carry a principle list, and no two agree.

| Principle in CLAUDE.md | Home in Architecture Principles.md |
|---|---|
| Invention is the root entity | AP-01 ✓ |
| Rules as data | AP-02 ✓ |
| Three-zone data separation | AP-03 ✓ |
| Plain language before legal terminology | AP-13 ✓ |
| Two-axis status model | AP-14 ✓ |
| **Cross-tenancy invisibility** | **none** (exists only as Phase 4 IA-5) |
| **Controlled vocabulary** | **none** (exists only as D-2026-011 / Phase 4 §10) |
| **Marketplace-first architecture** | **none** (D-2026-006 is a *regulatory* model, not an architectural one) |
| **Trust over convenience** | **none** (only implied by the Final Principle) |

README's list differs again — it adds "Long-term maintainability" and drops two-axis status, controlled vocabulary and cross-tenancy invisibility. Meanwhile AP-04…AP-12 (provenance, humans decide, Layer 1 = Layer 2, deadline safety, explainability, modular growth, honest product, global by design, documentation-as-product) appear in neither summary list.

**Effect:** the document declared permanent is not the document the operating instructions enforce.

## C. Terminology conflict at the governance layer

ADR §13.8 reserves **"Marketplace"** for the future licensing surface and renames the MVP concept **"Agent Matching / Engagement."** Phase 4 complies (`/app/find-an-agent`). But CLAUDE.md and README both list **"Marketplace-first architecture"** as a core principle to always preserve, using the term in exactly the retired sense. Under D-2026-011 (controlled vocabulary is the single source of truth), the two highest-authority documents in the repository violate the vocabulary rule.

## D. The Glossary contradicts its own governing decision

[Glossary.md](01_Strategy/Glossary.md) is 19 bare words with no definitions. D-2026-011 makes controlled vocabulary the single source of truth; Phase 4 §24.2 requires that in-product tooltips and `/learn/glossary/{term}` render from the same record and "cannot diverge." The actual glossary has no definitions to render, and its term set does not match the Phase 4 §10.2 lexicon (which carries ~24 concepts with separate client label, agent label, term of art, and banned synonyms). It also mixes domain terms with IA artifacts ("Silence View," "Context Switcher," "Information Architecture").

## E. Internal inconsistency inside Phase 4

Phase 4 §3 (global sitemap) lists the agent surface as Today / Docket / Matters / Opportunities / Practice / Settings — **`/agent/reviews` is absent.** But §6 (agent sitemap) defines it, §6.1 argues at length for it being a separate top-level destination, and §12.4 shows it in the navigation bar. The review queue is the BR-01 throughput gate and the most consequential addition the ADR made; §3 was not updated to match. Same-day dating (both 24 July 2026) suggests the ADR landed mid-document.

## F. Phase 3 role scope contradicted by the ADR

Phase 3 §4.1 defines **Reviewer** with scope = **Matter**. The ADR §4 states the assessment happens "with **no Engagement and no Matter in existence**," and §6 creates the review grant precisely because Phase 3's matter-scoped model cannot express pre-engagement access. The ADR §12 impact table notes that Phase 3 §4/§14 is "extended," but does not name the `Reviewer | Matter` row as superseded. Phase 4 §17.2 (what each role sees on a shared object) likewise has no row for a reviewer holding a review grant.

## G. Frozen documents carry superseded text with no forward pointer

The ADR §12 correctly records what it supersedes. But the superseded statements remain in the frozen documents with nothing marking them:

- Phase 3 J2 step 7 still reads "an honest time estimate (hours, not seconds)" — retired.
- Phase 3 M1.3 dependencies still read "Marketplace (reviewer assignment)" — superseded by queue-based routing.
- Phase 2 §10.3 unit economics still omit the assessment-review COGS line the ADR §8 adds.
- Phase 2 §13.4 conversion metric still reads ambiguously.

A reader who opens Phase 2 or Phase 3 directly — the likely behaviour for an engineer — gets the retired answer. There is no errata mechanism, and the freeze rule prevents adding one without a decision.

## H. The ADR's own instruction has no destination

ADR §8 and §14 state that platform-to-reviewer compensation "is added to the L1 register." The L1 register lives in Phase 4 §21.2 — which is frozen, lists 20 surfaces, and contains no such entry. There is no standalone L1 register document. The instruction was issued into a document that cannot receive it.

Relatedly, [Decision Log](01_Strategy/Decision%20Log.md) `O-2026-001` — the only open decision — has Status / Pending / Reason / Impact / Working Assumption but **no "Decision:" statement naming what is being decided**, and no cross-reference to the `L1` identifier used throughout Phases 3–5.

## I. Metric definitions with two denominators

Phase 2 §13.4: "≥25% of *completed assessments* convert to a paid engagement." Phase 2 §20.2: "**Disclosure → filing** conversion (target >25%)." These cannot both be 25% unless every disclosure produces an assessment. The same collision recurs at the failure threshold: §13.4's 15% is assessment-denominated, §18.4's ~15% is disclosure-denominated. The ADR §12 clarified the *assessment* metric only. The North Star (§20.1) is disclosure-denominated.

## J. Strategic tension the ADR acknowledged but did not reconcile

Phase 2 §8 Tier 0 (students, individual inventors, ICP-5 Suresh): *"Serve them with… nothing that requires human hours,"* and *"if this cohort ever exceeds ~5% of human-service capacity, we are running a charity inside a company."*

ADR §7 makes assessment **free to the client, universally**, and ADR §8 makes every assessment carry a **platform-paid human review cost**. Free assessment for Tier 0 is therefore, by construction, human-service capacity consumed by the cohort Phase 2 said must never consume it. ADR §9.4 acknowledges that free assessments and paid filings draw on overlapping reviewer capacity and calls it "an operational reality… not a condition to be assumed away" — an honest statement, but not a reconciliation with the 5% rule. No gate, quota or eligibility rule exists anywhere in the flows.

## K. Phase numbering has drifted from Phase 1's roadmap

Phase 1 §8 proposed: 5 = design system, 6 = key screens, 7 = technical architecture, 8 = pricing, 9 = SEO/GTM, 10 = build roadmap. Executed: 5 = user flows. Downstream, **Phase 6 has three different names in three documents** — "Wireframes" (README), "UX Design" (ADR header), "UX & Interaction Design" (Phase 5 §12). Phase 1's phases 7–10 (technical architecture, pricing, GTM, build roadmap) have no home in the current README roadmap, which runs 6 Wireframes → 7 Design System → 8 UI → 9 Development.

## L. Stale status markers

README shows **"⏳ Phase 5 – User Flows"** as pending; [Phase-5-User-Flows v1.0.md](02_Product/Phase-5-User-Flows%20v1.0.md) is complete and closes with a consistency statement. [Roadmap.md](01_Strategy/Roadmap.md) still reads "Next: Phase 5 — User Flows."

## M. Product name resolved in practice, never recorded

Phase 3 §26.3 P4 requires confirmation of brand and product naming because it affects IA labelling. Phases 2–4 use `[Platform]` and `[Mark]` placeholders throughout. Phase 5 is titled "ALDASSIST" and uses the name in body text. The decision was made somewhere and never entered in the Decision Log — the same is true of Phase 3 §26.3 P5 (minimum sample size for publishing agent outcome statistics; M2.4 *proposes* n=20, nothing accepts it).

## N. Repository has no version control

`.gitignore` exists and is empty; there is no `.git` directory. The workflow in README — Research → Proposal → Review → Decision → Documentation → **Freeze** — has no enforcement mechanism, no history, and no way to demonstrate that a frozen document has not changed.

---

# 5. Questions Before Future Work

Grouped by whether they block Phase 6, block engineering, or are repository hygiene.

## Blocking Phase 6

1. **What is Phase 6?** Wireframes (README), UX Design (ADR), or UX & Interaction Design (Phase 5 §12)? Phase 5's handoff notes describe interaction design; README's roadmap separates Wireframes (6) from Design System (7) from UI (8). I need the definition before scoping.

2. **§9-A — the "Responding" state.** Phase 5 flags that MVP files and tracks but cannot prosecute in-product. When an application reaches **Responding**, does the client see (a) an in-product status view with off-platform agent handling, or (b) an explicit "your agent is handling this off-platform" bridge? Phase 5 says either is faithful and the choice changes Phase 6 screens.

3. **Assumptions A1–A3.** Phase 5 §11 asks for explicit confirmation before Phase 6 finalises the affected flows: A1 (account and Workspace are distinct; Workspace created on first Disclosure), A2 (no client↔agent messaging outside active matters; no client↔reviewer channel), A3 (one Disclosure has one editing owner at a time; multi-inventor co-editing is sequential). A3 in particular is a conservative narrowing of a real baseline gap.

4. **L1 mode for Phase 6.** Phase 6 must design both PriceDisplay modes regardless — but has legal review advanced far enough to indicate which mode is likely, so the primary design can be the probable one?

## Blocking or shaping engineering

5. **Free assessment vs Tier 0 capacity (item J).** Is there a gate on free assessments — eligibility, quota, rate limit, or none? "None" is a legitimate answer, but it should be a recorded decision rather than an unexamined consequence, because it directly sizes the reviewer pool and the COGS line.

6. **Where does the extended L1 register live (item H)?** Phase 4 §21.2 is frozen. Options: a standalone `L1-Register.md` in `06_Legal` that supersedes it, an addendum, or a new ADR. This is a governance decision, not mine to make.

7. **Do frozen documents get supersession markers (item G)?** Four statements in Phases 2–3 now read as current but are retired. Options: an errata/supersession document, a permitted header banner on frozen files, or accept that the ADR is the sole authority and readers must consult it first. Each has a different cost.

8. **Phase 3 §26 dependency status.** Have any of D1–D6 been investigated — IP India programmatic access and terms (TA-2, the single largest external technical risk), EPO/USPTO/WIPO current API terms, model-provider no-training terms (TA-9, which if it fails forces self-hosted Zone 1 inference)? These shape architecture, not just schedule.

9. **Phase 3 §26.3 P3** — are Institution modules (Layer 3) V2 as written, or can they slip to V3? Phase 5 §10 assumes V2.

## Repository hygiene

10. **Should the Stage Gate Review be reconstructed or archived as lost (item A1)?** It is cited by section number from two documents. If a copy exists outside the repository, it belongs in `01_Strategy` or `08_Meetings`.

11. **Should I author the four empty spine documents (item A2)?** My reading is that Product Vision, Product Philosophy and Assumptions would be *extractions* from Phase 2 §§0–3 into durable, implementation-independent form — no new decisions, nothing invented. PROJECT_CONTEXT.md is different: it needs to say what the repository is, where the baseline sits, and what is frozen, which is partly a decision about how the repository should be entered. Confirm the extraction framing before I write anything.

12. **Should the Glossary be regenerated from the Phase 4 §10.2 lexicon (item D)?** That would make D-2026-011 true rather than aspirational. It is mechanical — plain-language definition, term of art, client label, agent label, banned synonyms per term — but it changes a strategy-folder document, so I want approval.

13. **Should the three principle lists be reconciled (item B), and in which direction?** Either Architecture Principles.md gains AP-15 (cross-tenancy invisibility), AP-16 (controlled vocabulary) and AP-17 (trust over convenience), or CLAUDE.md and README are amended to cite only what AP already contains. The first is more faithful to what the phases actually enforce; the second avoids touching a permanent document. I recommend the first, with "Marketplace-first architecture" replaced by the ADR-compliant wording, but this is exactly the kind of permanent decision I should not take unilaterally.

14. **Should the Decision Log be brought current (items H, M)?** Missing: product naming (ALDASSIST), minimum sample size for agent statistics, and a proper "Decision:" statement plus L1 cross-reference on O-2026-001. Adding entries is additive rather than a modification of frozen work, but the log is a governance artifact.

15. **Should README's roadmap and Roadmap.md be updated (item L)?** Both currently show Phase 5 as pending. Also: are Phase 1's originally-proposed phases 7–10 (technical architecture, pricing & packaging, SEO/GTM, build roadmap) still planned, and where do they sit in the current numbering?

16. **Should the repository be placed under git (item N)?** Freeze is the central governance mechanism and currently has no enforcement or history.

---

**Phase 6 has not been started, and nothing in the repository was modified.** My recommendation for the next unit of work — subject to your direction — is the hygiene set (items 10–16), because it is additive, non-architectural, and every one of those gaps will otherwise be inherited by Phase 6 and everything after it. But the three Phase-6-blocking questions (1–3) are worth answering regardless, since they gate the substantive work.